Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hemorrhage: full-pipeline trial registry
11 of 21 indexed Hemorrhage trials are currently recruiting.
Corpus placement: #797 of 28,707 conditions by registered trial count.
21 US clinical trials · 11 currently recruiting · #797 of 28,707 conditions by registered trial count
Hemorrhage: 21 US clinical trials tracked, 11 recruiting.
Hemorrhage is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 4 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is University of Colorado, Denver, running 3 of these trials.
Enrollment posture brief
Registry condition hemorrhage
OPEN 11 | RECR 52% | LATE 4 | EARLY 4 | RANK #797 | SPON 3
Volume-matched condition peers
Nearest open-share peer: End-Stage Kidney Disease (52% recruiting · 21 trials)
Hemorrhage lists 11 open slots (52% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hemorrhage on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hemorrhage is recruiting above its size-band peers.
11 of 21 indexed trials (52.4%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hemorrhage trials is spread across many organizations.
University of Colorado, Denver accounts for 3 of 21 trials (14.3%). 19 distinct sponsors appear on at least one study for this condition label.
-
Typical Hemorrhage enrolment sits around 119 participants.
Median target enrolment is 119 among the 21 trials that report a genuine target (sentinel values excluded). 9 of those (42.9%) plan for fewer than 100 participants.
-
Hemorrhage splits between interventional and observational designs.
11 interventional and 10 observational studies make up this index (52.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
21 total, page 1 of 1
CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Jason Sperry
NCT05958342
Pharmacogenomics of Warfarin in Hispanics and Latinos
University of Arizona
NCT02972385
Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes
University of California, San Diego
NCT06820177
Consortium for Optimized Integration of Bio-Artificial Blood Components for Adaptive Resuscitation Therapy
University of Maryland, Baltimore
NCT05756426
Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
University of Colorado, Denver
NCT06141447
Onyx™ Liquid Embolic IDE Clinical Study
Medtronic Endovascular
NCT06742801
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
Corza Medical
NCT06664775
NIRS Monitoring in Premature Infants
Boston Children's Hospital
NCT02601339
The Effect of Fluids on Aortic VTI During C-section
Baylor College of Medicine
NCT04330742
Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study
University of Minnesota
NCT06345833
Q Therapeutic System for Chronic Stroke Recovery
Burke Rehabilitation Hospital
NCT06979466
A Comparison of Hemorrhagic and Ischemic Strokes Among Blacks and Whites
University of Cincinnati
NCT00642213
Quantra QStat in Trauma and Liver Transplant
HemoSonics
NCT04312958
Non-invasive Hemodynamic Monitoring During Blood Donation for Developing Models of Early Blood Loss
University of Colorado, Denver
NCT01448694
TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery
Takeda
NCT01192022
Obsidio™ Conformable Embolic Registry
Boston Scientific Corporation
NCT06170619
Comparison of Physiological Variables During Blood Donation
University of Colorado, Denver
NCT02029807
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation
University of Hawaii
NCT04651166
Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)
The Medicines Company
NCT00666328
Coagulation Factor Changes Associated With Postpartum Hysterectomies
Northwestern University
NCT00456547
Pulsatile Perfusion Therapy Phase II
Caroline Rickards
NCT05983744
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
| Phase 3 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hemorrhage records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hemorrhage trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hemorrhage page
21 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Hemorrhage trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Colorado, Denver sponsors the most Hemorrhage trials on record, review their full trial history before evaluating a specific study. See University of Colorado, Denver's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemorrhage condition card totals 21 registered trials; most-linked intervention Blood Draw; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.